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Background: The NADH-ubiquinone oxidoreductase flavoprotein gene (NDUFV2), which encodes a 24 kD
mitochondrial complex I subunit, has been reported to be positively associated with schizophrenia and bipolar
disorder in different populations.
Methods: We genotyped the promoter variants of this gene (rs6506640 and rs1156044) by direct sequencing in
529 unrelated Han Chinese schizophrenia patients and 505 matched controls. Fisher’s Exact test was performed to
assess whether these two reported single nucleotide polymorphisms (SNPs) confer susceptibility to schizophrenia
in Chinese.
Results: Allele, genotype and haplotype comparison between the case and control groups showed no statistical
significance, suggesting no association between the NDUFV2 gene promoter variants and schizophrenia in Han
Chinese.
Conclusion: The role of NDUFV2 played in schizophrenia needs to be further studied. Different racial background
and/or population substructure might account for the inconsistent results between studies.
Background
Mitochondrial dysfunction was considered as a risk
factor for the onset of schizophrenia and other
psychiatric disorders [1]. As a core component of
mitochondrial respiratory chain, the 24 kD subunit of
mitochondrial complex I, NADH-ubiquinone oxidore-
ductase flavoprotein (NDUFV2), is a hot candidate
target for psychiatric disorders [2-7]. The first clue
that indicated a potential positive association of the
NDUFV2 gene with schizophrenia could be traced to the
pioneer association and linkage study by Schwab and col-
leagues [8], in which they reported chromosome 18p
(which contains this gene), conferred susceptibility to
functional psychoses in families with schizophrenia. Subse-
quent analyses showed a decreased level of NDUFV2
expression in postmortem prefrontal cortex and striatum
of schizophrenia patients [9-11] and in lymphoblastoid cell
line of Caucasian schizophrenia patients [4], suggesting an
active involvement of NDUFV2 in schizophrenia. Recent
association studies further indicated that the NDUFV2
promoter haplotype, which was constituted by two SNPs
(rs6506640-rs1156044), was significantly associated with
schizophrenia in Japanese population [5]. This association
was also found in patients with bipolar disorder from
different populations [6,7,12,13]. Among these studies,
SNP rs1156044 (which is located in position -602 relative
to the transcription start site) was suggested to be
responsible for the altered expression change in
patients. In particular, the “A” allele of this SNP could
lead to a significantly reduce of the promoter activity
[12]. Note that this seemingly deleterious A allele is
the major allele in the HapMap populations [14].
Assume that the altered expression of the NDUFV2
gene account for the reported positive association, one
would expect more people suffer from this “abnormal”
allele. In this study, we genotyped two promoter var-
iants (rs6506640 and rs1156044) of the NDUFV2 gene
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zophrenia susceptibility in Han Chinese.
Methods
Subjects
A total of 529 unrelated patients with schizophrenia
and 505 matched healthy controls, all of Han Chinese
origin, were recruited from Hunan Province in South
Central China. The schizophrenia was clinically diag-
nosed according to DSM-IV. Informed consent was
obtained from all participants or the supervisors of the
patients prior to this study. Diagnosis and review of
psychiatric case records were independently checked
and verified by two senior psychiatrists. The controls
were clinically diagnosed as no psychiatric disorders or
other diseases and were well matched in geographic
origin and ethnicity with the schizophrenia patients.
The institutional review boards of Kunming Institute
of Zoology and Central South University approved this
study.
Genotyping
The two SNPs (rs6506640 and rs1156044) were ampli-
fied independently by PCR and were genotyped by
direct sequencing method using ABI PRISM 3730
Genetic Analyzer (Perkin-Elmer Applied Biosystems).
PCR amplification was performed in a volume of 25 μL
containing primer pair for each SNP (for rs6506440:
5’-AAAGACGGTGGTCTACTGTG-3’/5’-GGTCTC-
CCAACCCTAATC-3’; for rs1156044: 5’-CAGAAAA-
GAAGGCAGTGACG-3’/5’-CCTCATGGAGAGCC-
TTGTG-3’) .T h eP C Rp r i m e r sw e r ea l s ou s e df o r
sequencing. Sequencing results were handled by the
DNASTAR program (DNASTAR Inc.) and the original
sequencing chromatograms of each sample were
further checked by eyes. A few samples were randomly
selected and were independently sequenced to evaluate
the genotype accuracy, and the results were well
matched between different runs.
Statistical analysis
The allele, genotype and haplotype frequencies of both
SNPs were compared between case and control samples
by the Fisher’s Exact Probability Test. Deviation from
the Hardy-Weinberg equilibrium was calculated by
using Monte Carlo permutation test through HWsim
program [15]. Linkage disequilibrium (LD) was calcu-
lated by Arlequin3.01 software [16]. PHASE2.1.1
program [17] based on the Bayesian method was used
to infer haplotype of the two SNPs.
Results and discussion
No deviation from the Hardy-Weinberg equilibrium was
found for both rs6506640 and rs1156044 in the control
subjects and schizophrenia patients in our study
(Table 1). The two SNPs were strongly linked with each
other (|D’|=0 . 9 8 ,r
2 =0 . 9 5i nc o n t r o l s ;| D’| = 0.98,
r
2 = 0.93 in patients). Consistent with previous reports
in Japanese [5], we observed no association in allele and
genotype comparisons between the case and control
groups (Table 1). There was no significant difference in
haplotype frequencies (Table 2) between the case and
control groups; these results were in contrast to pre-
vious finding for positive associations between haplo-
types A-G, G-A and G-G with schizophrenia [5].
Compared with western Eurasian, Chinese popula-
tion is genetically close to Japanese population and
they may share nearly same genetic background in dis-
ease. In order to unravel the reason of non-replicated
association between NDUFV2 gene polymorphisms and
schizophrenia in Han Chinese population, we down-
loaded the normal Han Chinese and Japanese data
from HapMap and performed a comparison to discern
potential bias in sampling. As only rs1156044
was available in HapMap database, we performed
intra-population comparison for this SNP (Table 3).
Our control population (CT-HC; sample 2 in Table 3)
was significantly different from the Han Chinese data
in HapMap (CT-CHB+CHD; sample 5) in allele
Table 1 Distribution of the NDUFV2 gene promoter variants in Han Chinese with and without schizophrenia




A/A (%) A/G (%) G/G (%) A (%) G (%)
rs6506640
SZ-HC (n = 529) 294 (55.6) 196 (37.0) 39 (7.4) 0.179 784 (74.1) 274 (25.9) 0.113 0.551
CT-HC (n = 505) 298 (59.0) 183 (36.2) 24 (4.8) 779 (77.1) 231 (22.9) 0.689
rs1156044
SZ-HC (n = 529) 292 (55.2) 195 (36.9) 42 (7.9) 0.142 779 (73.6) 279 (26.4) 0.075 0.396
CT-HC (n = 505) 299 (59.2) 180 (35.6) 26 (5.2) 778 (77.0) 232 (23.0) 0.914
Note: SZ = schizophrenia; HC = Han Chinese; CT = control.
a Two-tailed Fisher’s Exact Probability Test was used to quantify the allele difference between the case and control groups.
b The Hardy-Weinberg Equilibrium was computed by Monte Carlo permutation test (10000 simulations).
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(P = 0.076). In contrast, the Japanese control population
(CT-JP; sample 4) reported by Washizuka et al. [5] was
not significantly different to the HapMap Japanese data
(CT-JPT; sample 6) in allele frequency (P = 0.663),
but reached statistical difference in genotype frequency
(P = 0.041). The difference between Han Chinese con-
trol populations reported in this study and HapMap was
caused by CT-CHB (CT-HC vs. CT-CHB, P =0 . 0 3 2 ;
CT-HC vs. CHD, P = 0.251), as this population was
from north China and populations from north and
south China are quite different according to a recent
g e n o m e - w i d ea s s a y[ 1 8 ] .A l lt h es u b j e c t sr e c r u i t e di n
this study were from Hunan Province which is located
in southern China, thereby presented genetic difference
to CT-CHB. The exact reason for the observed differ-
ence between the Japanese control population and those
from HapMap was unknown, as there was no detailed
information regarding the Japanese control sample in
Washizuka et al.’s study [5]. It thus seems that potential
bias on non-random sampling and population substruc-
ture might account for the marvelous differences in
both allele and genotype frequencies of rs1156044 in
different populations (Table 3).
Despite a fact that “A” allele of rs1156044 was
reported to decrease the promoter activity in functional
assay [12], this functional deficiency does not seem to
be the causal factor for schizophrenia in Han Chinese.
The lack of association in allele, genotype and haplotype
with schizophrenia in our study indicates that the pro-
posed effect of the NDUFV2 gene on schizophrenia
should be treated with caution. Racial difference and/or
population substructure may account for the inconsis-
tent results between Han Chinese and Japanese as
observed in this study. It should be mentioned that the
most significant haplotypes (A-G and G-A) found by
Washizuka et al. [5] were rare haplotypes, which could
be more easily influenced by the small sample size (199
patients vs. 221 controls). Evidently, the utilization of
public HapMap database undoubtedly provides insight-
ful information in association study, especially when
inconsistent results were reported.
Limitations
There are several limitations that should be addressed in
the present study. First, we did not sequence the entire
promoter region of the NDUFV2 gene and no other tag-
ging SNPs of this gene was genotyped, so we could not
rule out the possibility that other unreported promoter
variant(s) and/or haplotype(s) affected the expression of
this gene. Second, only Han Chinese sample from
Hunan Province was recruited in this study, and this
might not necessarily eliminate the potential bias
regarding the sampling. Finally, we did not put the data
for other confounding factors (e.g. age, sex and so on)
into the logistic regression model to test whether they
would affect the associations for those two SNPs, as we
thought that the division of the current medium sized
case-control samples might cause type I error.
Conclusions
As increasing evidence to support “common disease rare
variant model” in schizophrenia in recent two years
Table 2 Haplotype distributions of SNPs rs6506640-
rs1156044 in Han Chinese with and without
schizophrenia
Haplotype A-A (%) A-G (%) G-A (%) G-G (%) P-value
a
SZ-HC 774 (73.2) 10 (0.95) 5 (0.47) 269 (25.4) 0.232
CT-HC 774 (76.6) 5 (0.5) 4 (0.4) 227 (22.5)
Note: SZ = schizophrenia; HC = Han Chinese; CT = control.
a two-tailed Fisher’s Exact Probability Test P value.
Table 3 Analysis of the reported allele and genotype frequencies of rs1156044 in Han Chinese and Japanese
Population and sample size Genotype P-value
a Allele P-value
a Data source
A/A (%) A/G (%) G/G (%) A (%) G (%)
1. SZ-HC (n = 529) 292 (55.2) 195 (36.9) 42 (7.9) 0.023 (1 vs. 3) 779 (73.6) 279 (26.4) 0.005 (1 vs. 3) This study
0.018 (1 vs. 4) 0.044 (1 vs. 4)
0.346 (1 vs. 5) 0.459 (1 vs. 5)
2. CT-HC (n = 505) 299 (59.2) 180 (35.6) 26 (5.2) 0.0003 (2 vs. 3) 778 (77.0) 232 (23.0) 0.0004 (2 vs. 3) This study
0.001 (2 vs. 4) 0.001 (2 vs. 4)
0.076 (2 vs. 5) 0.030 (2 vs. 5)
3. SZ-JP (n = 212) 94 (44.3) 95 (44.8) 23 (10.8) 0.264 (3 vs. 6) 283 (66.7) 141 (33.3) 1.000 (3 vs. 6) Washizuka et al. 2006
4. CT-JP (n = 222) 99 (44.6) 106 (47.7) 17 (7.7) 0.041 (4 vs. 6) 304 (68.5) 140 (31.5) 0.663 (4 vs. 6) Washizuka et al. 2006
5. CT-CHB+CHD (n = 243) 123 (50.6) 103 (42.4) 17 (7.0) 0.055 (5 vs. 6) 349 (71.8) 137 (28.2) 0.187 (5 vs. 6) HapMap dataset
6. CT-JPT (n = 113) 55 (48.7) 41 (36.3) 17 (15.0) –– –– HapMap dataset
Note: SZ-HC and CT-HC refer to Han Chinese with and without schizophrenia, respectively. CT-CHB = Beijing Han Chinese from HapMap; CHD = Chinese in
Metropolitan Denver from HapMap; CT-JPT = Japanese in Tokyo from HapMap; SZ-JP and CT-JP refer to Japanese patients with and without schizophrenia from
Washizuka et al. [5]. We did not include the reported Han Chinese data in Zhang et al’s study [7] for comparison, as there is inconsistency about the sample size
in their text.
a two-tailed Fisher’s Exact Probability Test P value.
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mainly based on genome wide association studies
( G W A S s )[ 2 1 - 3 3 ] ,w es h o u l db em o r ec a r e f u lt or e p o r t
association between common variant (e.g. rs6506640
and rs1156044, all with MAF≈0.3) and schizophrenia.
More studies with large sample size and population
from different regions, as well as, functional assays
should be conducted to finally elucidate the role of
NDUFV2 in schizophrenia.
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